FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090617 [Registered on: 09/07/2025] Trial Registered Prospectively
Last Modified On: 26/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of Panchendriyavardhana Ghrita Pratimarsha Nasya and Amalaki Avaleha orally in Indriyapradoshaja Vikaras or Sensory Processing Disorders in children with Autism. 
Scientific Title of Study   Randomized comparative clinical study to evaluate the efficacy of Panchendriyavardhana Ghrita Pratimarsha Nasya and Amalaki Avaleha orally in Indriyapradoshaja Vikaras with special reference to Sensory Processing Disorders in children with Autism 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shruti K 
Designation  PG Scholar  
Affiliation  Sri Sri College of Ayurvedic Science and Research Hospital Banglore. 
Address  OPD No. 9 Dept of PG Studies in Kaumarabhritya, Sri Sri College of Ayurvedic Science and Research Hospital, 21st Km Kanakapura Rd, Udayapura PO, OB Chudahalli Bangalore Bangalore KARNATAKA, 560082 India

Bangalore
KARNATAKA
560082
India 
Phone  8296424581  
Fax    
Email  shrutikreddy08@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  R A Divyasri 
Designation  Professor 
Affiliation  Sri Sri College of Ayurvedic Science and Research Hospital Banglore. 
Address  OPD No. 9 Dept of PG Studies in Kaumarabhritya, Sri Sri College of Ayurvedic Science and Research Hospital, 21st Km Kanakapura Rd, Udayapura PO, OB Chudahalli Bangalore Bangalore KARNATAKA, 560082 India

Bangalore
KARNATAKA
560082
India 
Phone  9448939421  
Fax    
Email  divya_mesho@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  R A Divyasri 
Designation  Professor 
Affiliation  Sri Sri College of Ayurvedic Science and Research Hospital Banglore. 
Address  OPD No. 9 Dept of PG Studies in Kaumarabhritya, Sri Sri College of Ayurvedic Science and Research Hospital, 21st Km Kanakapura Rd, Udayapura PO, OB Chudahalli Bangalore Bangalore KARNATAKA, 560082 India

Bangalore
KARNATAKA
560082
India 
Phone  9448939421  
Fax    
Email  divya_mesho@yahoo.co.in  
 
Source of Monetary or Material Support  
OPD No. 9 Dept of PG Studies in Kaumarabhritya, Sri Sri College of Ayurvedic Science and Research Hospital, 21st Km Kanakapura Rd, Udayapura PO, OB Chudahalli Bangalore Bangalore KARNATAKA, 560082 India 
 
Primary Sponsor  
Name  Shruti K 
Address  OPD No. 9 Dept of PG Studies in Kaumarabhritya, Sri Sri College of Ayurvedic Science and Research Hospital, 21st Km Kanakapura Rd, Udayapura PO, OB Chudahalli Bangalore Bangalore KARNATAKA, 560082 India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shruti K  Sri Sri College of Ayurvedic Science and Research hospital banglore  OPD No. 9 Dept of PG Studies in Kaumarabhritya, Sri Sri College of Ayurvedic Science and Research Hospital, 21st Km Kanakapura Rd, Udayapura PO, OB Chudahalli Bangalore Bangalore KARNATAKA, 560082 India
Bangalore
KARNATAKA 
8296424581

shrutikreddy08@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRI SRI INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F199||Other psychoactive substance use,unspecified. Ayurveda Condition: SROTRADINDRIYAGATAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Panchendriyavardhana Ghrita, Reference: Kashyapa Samhita, Route: Nasal, Dosage Form: Ghrita, Dose: 2(drops), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Amalaki Avaleha, Reference: Charaka Sanhita, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Milk), Additional Information: Dosage varies according to age. for 3 years - 3g, 4-5years-4g,4-5 years - 5g,5-6 years-6grams
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  6.00 Year(s)
Gender  Both 
Details  1.Subjects between the age group of 3year – 6 years.
2. Subjects diagnosed with autism through DSM 5 criteria.
 
 
ExclusionCriteria 
Details  1.Subjects who are known case of ADHD and the other syndromes will be excluded.
2. Subjects who are known case of other systematic illness will be excluded.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary outcome :
Significant improvement in Indriyapradoshaja Vikaras with special reference to Sensory Processing Disorders in children with Autism assessed on Child Sensory Profile 2.
Secondary outcome :
Generation of in – depth analyzed data on the different aspects of the disease .
Generation of data on possible unexpected drug reaction.


 
0th day, 30th day, 60th day, 90th day  
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome :
Generation of in – depth analyzed data on the different aspects of the disease .
Generation of data on possible unexpected drug reaction.
 
1 year 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [shrutikreddy08@gmail.com].

  6. For how long will this data be available start date provided 05-06-2025 and end date provided 05-06-2030?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Childhood is the period of physical, cognitive and social development that begins at birth and continues through early adulthood. Childhood is a time of imagination and creativity. Sensory experiences in childhood play a vital role in developing neural connection and pathways that are essential for learning, memory and overall cognitive development.

Autism comprises of multiple deficits that are yet to be understood, one of them being the sensory difficulties which are collectively termed as Sensory Processing Disorders (SPD). Rate of Sensory Processing Dysfunction may be as high as 90% in individual with autism. The abnormal sensory reactivity is associated with severity of autism, poor functional outcomes and behavioural difficulties including anxiety disorders across the lifespan. Early characterization of sensory abnormalities would be of tremendous value for guiding therapeutic interventions.

But in practice it is observed that the prime focus of parents and medical fraternity in the management of autism lies in the initiation of speech and correction of social behaviour, Sensory Dysfunction being paid less attention most of the times. Sensory Integration Therapy is a gold standard approach aimed at improving Sensory Processing in such children. Several studies are conducted in Ayurveda on Autism, but they lack a specific approach to sensory dysfunction.

SPD can be considered as Indriyapradoshaja Vikaras mentioned in Ayurveda where there is Upatapa (Vaikalya - Partial loss of function or altered function) and Upaghata (Nasha- Total loss of Functions, may be Permanent or Temporary) of Indriyas that leads to the

 

dysfunction of sensory pathways. 

(3) (4)

Indriyapradoshaja Vikaras may be treated on lines of Shiromarma Chikitsa as well with Rasayana Dravyas which facilitate the restoration of sensory functions. Shiromarma Chikitsa includes Nasya, Abhyanga, Snehapana etc. There are several Rasayana Yogas mentioned in classics which are said to be Buddheendriyabalaprada (Strengthening the sensory organs), few of them being Amalaki Avaleha, Amalaki Churna, Amalaki Ghrita, Panchama Haritaki Yoga, And Panchendriyavardhana Ghrita. These Yogas may be administered in the form of Nasya or orally as indicated which can correct the deranged function of Indriyas and their entire pathway. Thus, considering the fact that the sensory abnormalities in Autism and its remedies are unexplored through Ayurveda and a specialized approach to SPD is the need of the day, two different approaches are planned to be studied in SPD.

Thus, the current study is aimed at finding the efficacy of Panchendriyavardhana Ghrita Pratimarsha Nasya and Amalaki Avaleha orally in Sensory Processing Disorders, with special reference to Indriyapradoshaja Vikaras in children with Autism.

 
Close